Steve Postal, KD, director of policy and regulatory affairs at the National Community Pharmacists Association, shared an overview of federal- and state-level legislative, advocacy, and regulatory updates.
Steve Postal, KD, director of policy and regulatory affairs at the National Community Pharmacists Association, shared an overview of federal- and state-level legislative, advocacy, and regulatory updates that will impact affect independent pharmacies in the coming months, including PBM reform, pharmacist provider status, and the inflation reduction act.
ICER Finds Insurers Struggled to Provide Fair Access to Obesity Drugs
February 17th 2025The Institute for Clinical and Economic Review assessed the formularies of 11 payers, covering 57 million people, to determine access to drugs that the organization had reviewed for cost effectiveness in 2022.